Top BLOG Post 2-10-2009

- Study Reinforces Hormone Therapy And Breast Cancer Link
Stanford researchers have published the results of a study that reinforces the link between postmenopausal hormone replacement therapy and increased incidence of breast cancer.
According to the study results, women who take combined estrogen plus progestin hormone therapy for at least five years after menopause, have twice the annual risk of developing breast cancer. The risk of breast cancer is not associated with women who only take estrogen.
Read the entire blog for the rest of the study highlights.

